BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang T, Kong J, Yang X, Shen S, Zhang M, Wang W. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis. J Surg Oncol 2020;121:524-37. [PMID: 31867746 DOI: 10.1002/jso.25815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Beal EW, Chen JC, Kim A, Johnston FM, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Clarke C, Staley C, Patel SH, Lambert L, Cloyd JM. Is CRS-HIPEC Still Indicated in Patients With Extraperitoneal Disease? J Surg Res 2022;277:269-78. [PMID: 35525209 DOI: 10.1016/j.jss.2022.04.007] [Reference Citation Analysis]
2 Li X, Li J, Liu K, Tan L, Liu Y. Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review. J Int Med Res 2020;48:300060520969473. [PMID: 33161814 DOI: 10.1177/0300060520969473] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vij M, Puri Y, Rammohan A, G G, Rajalingam R, Kaliamoorthy I, Rela M. Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review. World J Gastrointest Oncol 2022; 14(3): 607-627 [DOI: 10.4251/wjgo.v14.i3.607] [Reference Citation Analysis]
4 Wang T, Wang W, Zhang J, Yang X, Shen S, Wang W. Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma. Front Oncol 2020;10:598433. [PMID: 33363028 DOI: 10.3389/fonc.2020.598433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang T, Zhang J, Wang W, Yang X, Kong J, Shen S, Wang W. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis. Cancer Manag Res 2020;12:11015-29. [PMID: 33173335 DOI: 10.2147/CMAR.S272797] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Feng JY, Li XP, Wu ZY, Ying LP, Xin C, Dai ZZ, Shen Y, Wu YF. Sarcomatoid intrahepatic cholangiocarcinoma with good patient prognosis after treatment with Huaier granules following hepatectomy: A case report. World J Clin Cases 2022; 10(9): 2827-2833 [DOI: 10.12998/wjcc.v10.i9.2827] [Reference Citation Analysis]
7 Tang Y, Zhang T, Zhao Y, Chen Z, Ma X. Development and validation of a comprehensive radiomics nomogram for prognostic prediction of primary hepatic sarcomatoid carcinoma after surgical resection. Int J Med Sci 2021;18:1711-20. [PMID: 33746587 DOI: 10.7150/ijms.53602] [Reference Citation Analysis]
8 Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X. Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review. J Hepatocell Carcinoma 2021;8:1117-27. [PMID: 34522692 DOI: 10.2147/JHC.S325182] [Reference Citation Analysis]